Connection

Martin Witzenrath to Glycoconjugates

Back to Details
This is a "connection" page, showing publications Martin Witzenrath has written about Glycoconjugates.
Martin Witzenrath
Connection Strength
1.088
Glycoconjugates
  1. A Semi-Synthetic Glycoconjugate Vaccine Candidate for Carbapenem-Resistant Klebsiella pneumoniae. Angew Chem Int Ed Engl. 2017 11 06; 56(45):13973-13978.
    View in: PubMed
    Score: 0.700
  2. A Streptococcus pneumoniae Type 2 Oligosaccharide Glycoconjugate Elicits Opsonic Antibodies and Is Protective in an Animal Model of Invasive Pneumococcal Disease. J Am Chem Soc. 2017 10 18; 139(41):14783-14791.
    View in: PubMed
    Score: 0.175
  3. A semisynthetic Streptococcus pneumoniae serotype 8 glycoconjugate vaccine. Sci Transl Med. 2017 03 08; 9(380).
    View in: PubMed
    Score: 0.168
  4. Semisynthetic glycoconjugate vaccine candidate against Streptococcus pneumoniae serotype 5. Proc Natl Acad Sci U S A. 2017 10 17; 114(42):11063-11068.
    View in: PubMed
    Score: 0.044
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.